Aria CV Overview

  • Founded
  • 2010

Founded
  • Status
  • Private

  • Employees
  • 18

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.77M

  • Investors
  • 12

Aria CV General Information

Description

Developer of implantable cardiovascular devices designed to treat pulmonary hypertension. The company's devices reduce the workload on the heart and have the potential to enhance both the survival and quality of life of those suffering from pulmonary hypertension, enabling patients to improve outcomes by reducing the workload on the right side of the heart.

Contact Information

Website
www.ariacv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 2334 University Avenue West
  • Suite 190
  • Saint Paul, MN 55114
  • United States
+1 (651) 000-0000

Aria CV Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aria CV Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Jul-2022 $7.77M 000.00 Completed Generating Revenue
3. Accelerator/Incubator 17-Jun-2021 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 25-Feb-2020 $31M $38.8M 0000 Completed Clinical Trials - Phase 4
1. Early Stage VC (Series A) 07-Jul-2015 $7.8M $7.8M 000.00 Completed Clinical Trials - Phase 4
To view Aria CV’s complete valuation and funding history, request access »

Aria CV Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Aria CV’s complete cap table history, request access »

Aria CV Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of implantable cardiovascular devices designed to treat pulmonary hypertension. The company's devices reduce t
Therapeutic Devices
Saint Paul, MN
18 As of 2023
000.00
0000000000 0 000.00

000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
00000000000 0000000
Milan, Italy
00 As of 0000
000.00
00000000000 000.00

000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
00000000000 0000000
Kirkland, WA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aria CV Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InnovHeart Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
00000000 (00000000 Venture Capital-Backed Paris, France 00 0000 00000000000 0000
000000000 00000000 Private Equity-Backed Irvine, CA 000 00000 0000000 0000 00000
0000000 Venture Capital-Backed Herzliya, Israel 00 000.00 0000000000 0 000.00
You’re viewing 5 of 19 competitors. Get the full list »

Aria CV Patents

Aria CV Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210402159-A1 Implantable devices for reducing pulsatile pressure within a blood vessel Pending 25-Jun-2020 0000000000
EP-4025287-A1 Diffusion and infusion resistant implantable devices for reducing pulsatile pressure Pending 06-Sep-2019 0000000000
US-20220023614-A1 Diffusion and infusion resistant implantable devices for reducing pulsatile pressure Pending 06-Sep-2019 0000000000
US-20210069396-A1 Diffusion and infusion resistant implantable devices for reducing pulsatile pressure Active 06-Sep-2019 0000000000
US-11141581-B2 Diffusion and infusion resistant implantable devices for reducing pulsatile pressure Active 06-Sep-2019 A61M60/869
To view Aria CV’s complete patent history, request access »

Aria CV Executive Team (7)

Name Title Board Seat Contact Info
Karl Vollmers Ph.D Co-Founder, Chief Technology Officer & Vice President of Research & Development
John Scandurra Co-Founder & Chief Scientific Officer
Dan Gladney Chief Executive Officer, President & Board Member
Peter Delange Chief Technology Officer
Darshana Zaveri Chairman
You’re viewing 5 of 7 executive team members. Get the full list »

Aria CV Board Members (6)

Name Representing Role Since
Dan Gladney Self Chief Executive Officer, President & Board Member 000 0000
Darshana Zaveri Self Chairman 000 0000
George Fazio Self Board Member 000 0000
Jason Rushton Self Board Member 000 0000
Maria Berkman MD Broadview Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Aria CV Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aria CV Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MedTech Innovator Accelerator/Incubator Minority 000 0000 000000 0
Angel Physicians Fund Venture Capital Minority 000 0000 000000 0
Brightstone Venture Capital Venture Capital Minority 000 0000 000000 0
Frontcourt Group Investment Bank Minority 000 0000 000000 0
Long View Equity Partners Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »